In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

The BRAF mutation affects a small percentage of non-small cell lung cancer (NSCLC) cases, making the cancer more difficult to treat. In recent years, advances in treatment have helped to improve ...

Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the ...

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

New breast cancer pill eliminates tumor proteins and improves treatment response in patients by making the estrogen receptor ...

Researchers have pinpointed what could be the early genetic origins of breast cancer -- cancer-like mutations appearing in the cells of healthy women. In a new study, the international collaborators ...

It's a fundamental principle of science: Correlation does not equal causation. Every cancer cell has genetic mutations, but ...

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer. This ...